Calcium glycerophosphate
As of the edition of 20 October 2026, Calcium glycerophosphate is a drug: marketed, first approved in 1981 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2025
- Kind
- Unknown
- Brand name
- PreemieFort Enteral
- First approved
- 31 December 1981 (CA)
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- Clinigen; 2 holders in all
- Registered trials
- 1, 0 stopped early
- Disease areas
- Mouth and teeth
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 1 | 1 | 0 | 0 |
| All trials | 1 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Clinigen | Applicant | 2025 to now |